Decay of human immunodeficiency virus type 1 unintegrated DNA containing two long terminal repeats in infected individuals after 3 to 8 years of sustained control of viremia

Journal of Clinical Microbiology

Volumn 43, Issue 10, 2005, Pages 5272-5274

  McDermott, Jennifer L ^a,b   Martini, Isabella ^a,b   Ferrari, Davide ^a,b   Bertolotti, Francesca ^a   Giacomazzi, Claudio ^a,b   Murdaca, Giuseppe ^a   Puppo, Francesco ^a   Indiveri, Francesco ^a   Varnier, Oliviero E ^a,b  

^a UNIVERSITY OF GENOA   (Italy)

^b ADVANCED BIOTECHNOLOGY CENTER   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ARTICLE; CLINICAL ARTICLE; DNA DEGRADATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INFECTION CONTROL; LONG TERMINAL REPEAT; PRIORITY JOURNAL; VIREMIA; VIRUS INHIBITION; VIRUS REPLICATION;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DNA, VIRAL; HIV INFECTIONS; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; VIREMIA; VIRUS INTEGRATION; VIRUS REPLICATION;

DNA VIRUSES; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 26944490692     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.43.10.5272-5274.2005     Document Type: Article

References (18)

1. Cara, A., and M. S. Reitz, Jr. 1997. New insight on the role of extrachromosomal retroviral DNA. Leukemia 11:1395-1399.
2. Cara, A., J. Vargas, Jr., M. Keller, S. Jones, A. Mosoian, A. Gurtman, A. Cohen, V. Parkas, F. Wallach, E. Chusid, I. H. Gelman, and M. E. Klotman. 2002. Circular viral DNA and anomalous junction sequence in PBMC of HIV-infected individuals with no detectable plasma HIV RNA. Virology 292:1-5.
3. Chun, T. W., D. Finzi, J. Margolick, K. Chadwick, D. Schwartz, and R. F. Siliciano. 1995. In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency. Nat. Med. 1:1284-1290.
4. Donovan, R. M., C. E. Bush, S. M. Smereck, D. M. Baxa, N. P. Markowitz, and L. D. Saravolatz. 1994. Rapid decrease in unintegrated human immunodeficiency virus DNA after the initiation of nucleoside therapy. J. Infect. Dis. 170:202-205.
5. Finzi, D., M. Hermankova, T. Pierson, L. M. Carruth, C. Buck, R. E. Chaisson, T. C. Quinn, K. Chadwick, J. Margolick, R. Brookmeyer, J. Gallant, M. Markowitz, D. D. Ho, D. D. Richman, and R. F. Siliciano. 1997. Identification of a reservoir for HIV in patients on highly active antiretroviral therapy. Science 278:1295-1300.
6. Giacomini, M., J. L. McDermott, A. A. Giri, I. Martini, F. B. Lillo, and O. E. Varnier. 1998. A novel and innovative quantitative kinetic software for virological colorimetric assays. J. Virol. Methods 73:201-209.
7. Giri, A. A., F. B. Lillo, J. L. McDermott, C. Jannuzzi, S. Risso, G. L. Fornia, D. R. Concedi, and O. E. Varnier. 1994. Detection of HIV-1 sequences in children using radioactive and colorimetric polymerase chain reactions. J. Med. Virol. 42:414-419.
8. Hauber, I., T. Harrer, P. Low, M. Schmitt, E. Schwingel, and J. Hauber. 2000. Determination of HIV-1 circular DNA as a surrogate marker for residual virus replication in patients with undetectable virus loads. AIDS 14:2619-2621.
9. McDermott, J. L., A. A. Giri, I. Martini, M. Bono, M. Giacomini, A. Campelli, L. Tagliaferro, A. Cara, and O. E. Varnier. 1999. Level of human immunodeficiency virus DNA in peripheral blood mononuclear cells correlates with efficacy of antiretroviral therapy. J. Clin. Microbiol. 37:2361-2365.
10. Panther, L. A., R. W. Coombs, S. A. Aung, C. Della Rosa, D. Gretch, and L. Corey. 1999. Unintegrated HIV-1 circular 2-LTR proviral DNA as a marker of recently infected cells: relative effect of recombinant CD4, zidovudine, and saquinavir in vitro. J. Med. Virol. 58:165-173.
11. Pauza, C. D., P. Trivedi, T. S. McKechnie, D. D. Richman, and F. M. Graziano. 1994. 2LTR circular viral DNA as a marker of human immunodeficiency virus type 1 infection in vivo. Virology 205:470-478.
12. Perelson, A. S., P. Essunger, Y. Cao, M. Vesanen, A. Hurley, K. Saksela, M. Markowitz, and D. D. Ho. 1997. Decay characteristics of HIV-1-infected compartments during combination therapy. Nature 387:188-191.
13. Pomerantz, R. J. 2001. Reservoirs of human immunodeficiency virus type 1: the main obstacles to viral eradication. Clin. Infect. Dis. 34:91-97.
14. Saag, M. S., M. Holodniy, D. R. Kuritzkes, W. A. O'Brien, R. Coombs, M. E. Poscher, D. M. Jacobsen, G. M. Shaw, D. D. Richman, and P. A. Volberding. 1996. HIV viral load markers in clinical practice. Nat. Med. 2:625-629.
15. Sharkey, M. E., and M. Stevenson. 2001. Two long terminal repeat circles and persistent HIV-1 replication. Curr. Opin. Infect. Dis. 14:5-11.
16. Stevenson, M., S. Haggerty, C. A. Lamonica, C. M. Meier, S.-K. Welch, and A. J. Wasiak. 1990. Integration is not necessary for expression of human immunodeficiency virus type 1 protein products. J. Virol. 64:2421-2425.
17. Wong, J. K., M. Hezareh, H. F. Gunthard, D. Havlir, C. C. Ignacio, C. A. Spina, and D. D. Richman. 1997. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 278:1291-1294.
18. Zazzi, M., L. Romano, M. Catucci, G. Venturi, A. De Milito, P. Almi, A. Gonnelli, M. Rubino, U. Occhini, and P. E. Valensin. 1997. Evaluation of the presence of 2-LTR HIV-1 unintegrated DNA as a simple molecular predictor of disease progression. J. Med. Virol. 52:20-25.